borderline significantP = 0.06
Overall the drug tolerability was acceptable in both trials, except for a borderline significant ( P = 0.06) increased incidence of stroke in the aspirin group of the Baron study.
Overall the drug tolerability was acceptable in both trials, except for a borderline significant ( P = 0.06) increased incidence of stroke in the aspirin group of the Baron study.
A reduction in DCIS ipsilateral recurrences was noted but failed to reach statistical significance (Wapnir et al ., 2011 ).